Chime Financial Slides as Recent Insider Sales Likely Weigh on Shares
Investivoq PriceTracker
Chime Financial, Inc. (CHYM) is down 7.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely catalyst appears to be continued pressure from recent insider and major-holder stock sales rather than a fresh negative company announcement today. This could also be because investors are reassessing valuation after recent corporate updates, including Chime’s planned bank acquisition, while a wave of selling by large holders adds near-term supply to the stock.
Details:
Sources:
SEC, Chime Investor Relations, Benzinga
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CHYM Insider Trading Activity
$CHYM insiders have traded $CHYM stock on the open market 320 times in the past 6 months. Of those trades, 0 have been purchases and 320 have been sales.
Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:
- GLOBAL ADVISORS LTD DST has made 0 purchases and 280 sales selling 32,500,244 shares for an estimated $1,070,388,468.
- JAMES FEUILLE has made 0 purchases and 10 sales selling 799,527 shares for an estimated $26,335,559.
- CHRISTOPHER R BRITT (Chief Executive Officer) has made 0 purchases and 10 sales selling 850,000 shares for an estimated $26,271,578.
- SHAWN T CAROLAN has made 0 purchases and 6 sales selling 579,313 shares for an estimated $19,194,539.
- RYAN A KING (Co-Founder) has made 0 purchases and 4 sales selling 417,421 shares for an estimated $12,841,242.
- ADAM B FRANKEL (General Counsel) has made 0 purchases and 4 sales selling 108,002 shares for an estimated $3,504,105.
- MATTHEW S NEWCOMB (Chief Financial Officer) has made 0 purchases and 2 sales selling 65,000 shares for an estimated $1,961,000.
- AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 39,505 shares for an estimated $1,192,529.
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$CHYM Hedge Fund Activity
We have seen 178 institutional investors add shares of $CHYM stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ICONIQ CAPITAL, LLC removed 11,064,137 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $226,593,525
- COATUE MANAGEMENT LLC removed 10,071,992 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $206,274,396
- BLACKROCK, INC. added 9,819,060 shares (+688.9%) to their portfolio in Q2 2026, for an estimated $201,094,348
- TIGER GLOBAL MANAGEMENT LLC removed 8,908,454 shares (-62.8%) from their portfolio in Q2 2026, for an estimated $182,445,137
- POINT72 ASSET MANAGEMENT, L.P. removed 4,586,956 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $85,913,685
- SCGE MANAGEMENT, L.P. removed 4,181,827 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $85,643,816
- CITADEL ADVISORS LLC removed 3,709,869 shares (-55.9%) from their portfolio in Q1 2026, for an estimated $69,485,846
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$CHYM Price Targets
Multiple analysts have issued price targets for $CHYM recently. We have seen 5 analysts offer price targets for $CHYM in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Nik Cremo from Barclays set a target price of $26.0 on 07/08/2026
- Joseph Vafi from Canaccord Genuity set a target price of $40.0 on 05/11/2026
- Cassie Chan from Wells Fargo set a target price of $28.0 on 05/07/2026
- Andrew Bauch from BMO Capital set a target price of $30.0 on 04/22/2026
- Giuliano Bologna from Compass Point set a target price of $27.0 on 04/13/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.